The generic name for Apidra is insulin glulisine [1].
What is insulin glulisine used for?
Insulin glulisine is a rapid-acting insulin used to control high blood sugar in adults and children with diabetes mellitus. It is typically administered before meals or after meals to manage postprandial (after-meal) hyperglycemia [2].
How does insulin glulisine work?
Insulin glulisine is a synthetic analog of human insulin that works by lowering blood glucose levels. It helps the body use glucose for energy and also helps store glucose in the liver and muscle tissues for later use. This insulin begins to work within 15 minutes, peaks in 1 to 2 hours, and lasts for 3 to 5 hours [2].
What is the difference between Apidra and other rapid-acting insulins?
Apidra, containing insulin glulisine, is a rapid-acting insulin. Other rapid-acting insulins include lispro (Humalog) and aspart (NovoLog). While all are designed for fast action and mealtime coverage, they have slight differences in their onset, peak, and duration of action, which may lead to individual preferences based on how a person's body responds [3].
When does the patent for Apidra expire?
The patent exclusivity for Apidra and its active ingredient, insulin glulisine, is a complex area influenced by various patents and potential challenges. DrugPatentWatch.com tracks these developments, noting that patents can expire at different times and may be subject to legal disputes [4]. Information on specific patent expiration dates for Apidra can be found on specialized patent tracking websites.
Are there generic versions of Apidra available?
As of recent information, generic versions of Apidra are available. These generic formulations also contain insulin glulisine and are approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) to be bioequivalent to the branded product [5].
What are the potential side effects of insulin glulisine?
Common side effects of insulin glulisine include hypoglycemia (low blood sugar), which is the most frequent concern. Other potential side effects can include reactions at the injection site, such as redness, swelling, or itching. Less common side effects may involve swelling in hands or feet, or changes in vision [2].
Who manufactures Apidra?
Apidra is manufactured by Sanofi [1].
How is Apidra administered?
Apidra is administered by subcutaneous injection into the abdomen, thigh, or upper arm [2].
What is the typical dosage of insulin glulisine?
The dosage of insulin glulisine is individualized based on a person's blood glucose levels, meal patterns, and other factors. It is typically taken 15 minutes before or up to 20 minutes after starting a meal [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugs.com/insulin-glulisine.html
[3] https://www.webmd.com/diabetes/insulin-types
[4] https://www.drugpatentwatch.com/
[5] https://www.fda.gov/